Acurx Pharmaceuticals, Inc. Share Price
ACXPAcurx Pharmaceuticals, Inc. Stock Performance
Open $1.63 | Prev. Close $1.61 | Circuit Range N/A |
Day Range $1.59 - $1.68 | Year Range $1.37 - $21.00 | Volume 1,802 |
Average Traded $1.63 |
Acurx Pharmaceuticals, Inc. Share Price Chart
About Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia; and CCP, multiple product candidates for gram-positive infections. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.
Acurx Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
09-Jun-26 | $1.63 | $1.61 | +0.00% |
09-Jun-26 | $1.63 | $1.61 | +0.00% |
08-Jun-26 | $1.63 | $1.61 | -4.17% |
05-Jun-26 | $1.71 | $1.68 | -3.72% |
04-Jun-26 | $1.74 | $1.75 | +0.29% |
03-Jun-26 | $1.82 | $1.74 | -3.33% |
02-Jun-26 | $1.83 | $1.80 | -5.26% |